InvestorsHub Logo
Followers 55
Posts 2565
Boards Moderated 0
Alias Born 04/15/2012

Re: bradfordbros post# 139955

Tuesday, 02/16/2016 2:15:15 PM

Tuesday, February 16, 2016 2:15:15 PM

Post# of 403773
You are definitely more right than wrong:

I could be quite wrong but I think not putting more dollars in the till may be holding the stock back. The other way is to more clearly define trial financing or find a backer/partner.



Most anyone with experience in the Biotec sector will understand that adequate funding (cash on hand and lines of credit) is very important. The more the better.

I think CTIX is adequately funded, some do not. Problem is that, CTIX appears to be "just" adequately funded. And, this risk is clearly articulated in each quarterly and annual report.

My own view is that, like up listing, Leo seems to be complacent concerning the issue of financing. He is better with other priorities.

Financing can be a two edged sword. From my observations, most of the time, stocks initially suffer; but, longer term, benefit from reasonable financing. No one likes dilution. Running out of funds is much worse. Going to the markets for financing is almost always best when companies have maneuvering room.

Probably more important than Aspire for financing, is the shelf registration. Circumstances are better, in either case, when the share price is higher than lower.

Why oh why didn't Leo act on up listing and financing when the share price was very much higher? 20/20 hindsight. But, it shows that Leo's priorities can blind side him. I think, even he regrets not acting when times were better. Course, Leo has made some excellent calls, like the Polymedix Heist.

Now, Leo must want to get the price up. One reason I think he is likely to issue more frequent PR's, with much less importance. Hope he continues to be more aggressive. Hope he ups his game. Hope he achieves a higher share price. It would make his decision making much easier. Give him more options. Make shareholders happier.

Whatever it takes.